Nexium Stomach Cancer Claims Trimmed, But Louisiana Statutory Claims Survive

(August 28, 2019, 2:13 PM EDT) -- BATON ROUGE, La. — A Louisiana federal judge on Aug. 26 said a plaintiff who claims that the prescription heartburn drug Nexium caused his stomach cancer can’t make claims outside of the Louisiana Product Liability Act (LPLA) but otherwise said the plaintiff’s LPLA claims escape dismissal (Stanley P. Baudin v. AstraZeneca Pharmaceuticals L.P., et al., No. 18-1063, M.D. La., 2019 U.S. Dist. LEXIS 145210)....

Attached Documents

Related Sections